[New concepts on pathophysiology, diagnosis and treatment of adenomyosis].

Fernandez H, H. Fernandez
Journal de gynecologie, obstetrique et biologie de la reproduction · 2003 · vol. 32(8 Pt 2) , pp. S23–7 · PMID:14968064 · W2414562819
article OA: closed CC0 ⤵ 8 in-corpus citations
View on OpenAlex View on PubMed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This paper reviews current knowledge on adenomyosis pathophysiology, diagnosis with ultrasound or MRI, and treatment options including GnRH agonists, hormonal therapies, and conservative surgical procedures.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Adenomyosis is a relatively frequent disease, difficult to diagnose and which pathophysiology remains unknown. The treatment for the women which want to conserve or improve their fertility remains not well defined. Endovaginal ultrasonography seems to be as effective as MRI for the diagnosis of adenomyosis. Gn-RH agonist decreases symptoms and uterine volume; however, the symptoms reappear after discontinuation of agonist therapy, and side effects limit their prolonged use. Progestérone receptor modulators, anti-progestative and danazol or levonorgestrel-releasing intra-uterine system have been used as therapeutic modalities for adenomyosis, but the lack of controlled studies make their efficacy difficult to quantify. Some women with superficial adenomyosis may theoretically benefit from hysteroscopic myometrial or endometrial resection, but these procedures would be limited to women not wishing to conceive. Laparoscopic myometrial electrocoagulation or excision has proven to be effective but pregnancy following these techniques poses special problems, particularly the increased risk of uterine rupture. Transvaginal ultrasonography can successfully diagnose adenomyosis. Medical and conservative surgical treatments are already available.

My notes (saved in your browser only)

Condition tags

endometriosisadenomyosis

MeSH descriptors

Endometriosis Endometriosis Biopsy Embolization, Therapeutic Endometriosis Endometriosis Endometriosis Female Humans Hysterosalpingography Hysteroscopy Magnetic Resonance Imaging Pelvis Pelvis Risk Factors Ultrasonography

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

Cited by (8)

SciLite annotations

chemicals 2
danazol levonorgestrel

Source provenance

europepmc
last seen: 2026-08-26T06:08:41.316361+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:12:38.158000+00:00
scilite
last seen: 2026-05-18T04:57:49.680383+00:00
License: CC0 · commercial use OK